PDLI Related Corporate News

Apr 22, 2013 08:00 AM PDL BioPharma (PDLI) Enters $40M Financing Agreement w/ Avinger

Mar 4, 2013 07:30 AM PDL BioPharma (PDLI_ Ajusts Conversion Rates on Convertible Notes Offering

Jun 19, 2012 07:04 AM PDL BioPharma (PDLI) to Receive Royalties from Perjeta Sales (RHHBY)

Jan 4, 2012 06:35 AM PDL BioPharma (PDLI) Gets 93.9% Response in Notes Exchange Offer

Dec 12, 2011 07:12 AM PDL BioPharma (PDLI) Corrects Convertible Notes Coversion Rate for Upcoming Dividend

Jul 11, 2011 07:09 AM PDL BioPharma (PDLI) Receives Favorable Ruling Against Roche's (RHHBY) Genentech

May 24, 2011 07:10 AM PDL BioPharma (PDLI) Announces Convertible Senior Notes Redemption

Feb 28, 2011 07:17 AM EPO Upholds PDL BioPharma's (PDLI) 216B Patent

Aug 13, 2010 07:05 AM PDL BioPharma (PDLI) Receives Letter from Genentech (DNA) Relating to European Patents

Dec 21, 2009 04:34 PM PDL BioPharma (PDLI) Announces New Licensing Agreement with Eli Lilly (LLY)

Jan 5, 2009 09:07 AM Alexion Pharmaceuticals (ALXN) and PDL BioPharma (PDLI) Resolve Patent Dispute

Dec 10, 2008 05:18 PM S&P Announces Changes to US Indices: MASI for PDLI, CLW for PDGI

Aug 19, 2008 04:03 PM Bristol-Myers (BMY) and PDL BioPharma (PDLI) Announces Development Agreement

Aug 19, 2008 04:03 PM Bristol-Myers Squibb (BMY) and PDL BioPharma (PDLI) Enter Agreement

Apr 10, 2008 04:23 PM PDL BioPharma (PDLI) Declares Special Dividend of $4.25/Share; Will Spin-Off Biotech Assets

Mar 10, 2008 08:36 AM Otsuka Pharmaceutical and PDL BioPharma (PDLI) Close Sale of IV Busulfex

Mar 4, 2008 04:27 PM PDL BioPharma (PDLI) Concludes Strategic Review; Will Focus on Discovery and Development

Mar 4, 2008 04:16 PM PDL BioPharma (PDLI) Trading Halted--Pending News

Feb 4, 2008 04:29 PM EKR Therapeutics and PDL BioPharma (PDLI) Sign Asset Purchase Agreement for Cardiovascular Products

Oct 11, 2007 04:36 PM Biogen Idec Inc. (BIIB) and PDL BioPharma Inc. (PDLI) Announce Phase 2 Data On Daclizumab

Aug 29, 2007 03:56 PM Third Point Demands PDL BioPharma (PDLI) Chairman Gage Resign and Boards Focus on Prompt Sale

Aug 28, 2007 04:12 PM PDL BioPharma (PDLI) Announces Significant Strategic and Portfolio Changes; Hires Merrill Lynch to Advise

Aug 15, 2007 01:24 PM Summary of Loeb's Third Point LLC 13F

Jul 16, 2007 06:04 PM Third Point Reiterates Demand for Mark McDade to be Terminated as CEO of PDL BioPharma (PDLI)

May 31, 2007 01:51 PM Third Point LLC Sends Letter Requesting Removal of PDL BioPharma's (PDLI) CEO

May 7, 2007 05:29 PM PDL BioPharma (PDLI) Co-Founder Queen Supports Third Point LLC's Proposals for a New Direction

Apr 24, 2007 10:39 AM PDL BioPharma (PDLI) Says European Patent Claims Upheld

Apr 11, 2007 02:49 PM Loeb's Wants PDLI CEO Terminated, Raises Stake; Says Co Turned Away $30 Bid, Wants Split In Two

Mar 22, 2007 01:42 PM PDL BioPharm (PDLI) Responds to Third Point's 13D Filing

Mar 19, 2007 08:42 AM PDL BioPharma (PDLI) Files Lawsuit Against Alexion Pharmaceuticals (ALXN)

Dec 11, 2006 05:49 PM PDL BioPharma (PDLI) Announced Preclinical Data on HuLuc63 at the American Society of Hematology Annual Meeting

Nov 21, 2006 05:35 PM PDL BioPharma (PDLI) Says Roche to Discontinue Joint Agreement to Develop and Commercialize Daclizumab

Apr 13, 2005 09:04 AM SGEN In-licenses Anti-CD33 Antibody Program

Feb 2, 2005 04:12 PM PDLI Announces Ruling in European Patent Opposition Proceeding